Strong reduction in prevalence of HPV16/18 and closely related HPV types in sexually active adolescent women following the introduction of HPV vaccination in Argentina

IF 3.2 Papillomavirus Research Pub Date : 2020-12-01 DOI:10.1016/j.pvr.2020.100208

Joaquín Víctor González , Gerardo Daniel Deluca , Rita Mariel Correa , Domingo Javier Liotta , Jorge Alejandro Basiletti , María Dolores Fellner , María Celeste Colucci , Olga Gabriela Alzogaray , Nathalia Katz , Juan José Carmona , Néstor Fabián Tappari , Enrique Berner , Viviana Cramer , Paula Real , Carlota Viviana López Kaufman , Gabriela Judit Kosoy , Lucía Katabian , María Silvia Severino , Ricardo Enrique Aboslaiman , Cecilia Chami , María Alejandra Picconi

引用次数: 5

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

在阿根廷引入HPV疫苗接种后，性活跃的青春期妇女中HPV16/18和密切相关的HPV类型的患病率大幅下降

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Papillomavirus Research VIROLOGY-

自引率

0.00%

发文量

审稿时长

14 weeks

期刊介绍： The official Journal of the International Papillomavirus Society Papillomavirus Research (PVR), the Journal of HPV and other Small DNA Tumor Viruses publishes innovative papers related to all aspects of papillomaviruses and other small DNA tumor viruses. The official journal of the International Papillomavirus Society, PVR is an open access publication that aims to bring together virologists, immunologists, epidemiologists and clinicians working in the booming field of HPV and animal papillomaviruses, polyomaviruses and other small DNA tumor viruses and their associated diseases, in order to foster and facilitate interdisciplinary communication. The journal welcomes original research articles, reviews, short communications, opinion articles and regional update reports on papillomaviruses and other tumor viruses in the following sections: a. Biology of papillomaviruses and related viruses from life cycle to cancer b. Epidemiology etiology and natural history studies c. Natural and induced immunity including vaccine research d. Intervention studies and strategies including i. Clinical studies and trials ii. HPV treatments iii. HPV vaccination programs iv. Diagnostics and screening e. Infection and disease prevention, modeling studies f. Guidelines and public health recommendations g. HPV Studies in special populations Regional and local studies on these viruses.